Stock 4519 CHUGAI PHARMACEUTICAL CO., LTD
Add to a list
To use this feature you must be a member
Log inSign up

Company Chugai Pharmaceutical Co., Ltd

Equities

4519

JP3519400000

Pharmaceuticals

Market Closed - Japan Exchange
Other stock markets
 02:00:00 2024-07-03 am EDT 		5-day change 1st Jan Change
5,983 JPY +3.40% Intraday chart for Chugai Pharmaceutical Co., Ltd +2.94% +12.00%
Jul. 02 Financials lift Japanese shares on rate-hike speculation RE
Jun. 24 Japan's Nikkei ends choppy session on stronger note RE

Business Summary

Chugai Pharmaceutical Co. Ltd specializes in the research, development, manufacturing and marketing of drugs especially for cancers (40.8% of net sales), bones and joints diseases treatment (18.4%), and kidney diseases (5.9%).

Net sales are distributed geographically as follows: Japan (74,3%), Switzerland (22,8%) and other (2,9%).

Number of employees: 7,604

Sales per Business

JPY in Million2022Weight2023Weight Delta
Pharmaceuticals
87.7 %
1,039,247 82.5 % 974,493 87.7 % -6.23%
Other
12.3 %
91,915 7.3 % 136,874 12.3 % +48.91%

Sales per region

JPY in Million2022Weight2023Weight Delta
Japan
50.3 %
657,273 52.2 % 559,233 50.3 % -14.92%
Switzerland
46.1 %
482,736 38.3 % 511,880 46.1 % +6.04%
Overseas
3.6 %
119,936 9.5 % 40,253 3.6 % -66.44%

Managers

Managers TitleAgeSince
Osamu Okuda CEO
 Chief Executive Officer 61 87-03-31
Junichi Nezu CTO
 Chief Tech/Sci/R&D Officer - -
Hisafumi Okabe CTO
 Chief Tech/Sci/R&D Officer - -
Motoo Ueno BRD
 Director/Board Member 66 84-03-31
Yoko Kitagawa IRC
 Investor Relations Contact - -
Keiji Kono IRO
 Public Communications Contact - -
Yoshiaki Ohhashi PRN
 Corporate Officer/Principal - -
Yoshiyuki Yano HRO
 Human Resources Officer - -
Shinji Hidaka SAM
 Sales & Marketing - -
Atsushi Sato AUD
 Comptroller/Controller/Auditor 65 81-03-31

Members of the board

Members of the board TitleAgeSince
Masayuki Oku BRD
 Director/Board Member 79 15-02-28
Motoo Ueno BRD
 Director/Board Member 66 84-03-31
James H. Sabry BRD
 Director/Board Member 65 19-02-28
Christoph Franz BRD
 Director/Board Member 64 17-02-28
Yoichiro Ichimaru BRD
 Director/Board Member 75 17-02-28
William Anderson BRD
 Director/Board Member 57 19-02-28
Osamu Okuda CEO
 Chief Executive Officer 61 87-03-31
Mariko Momoi BRD
 Director/Board Member 76 20-02-29

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 0 1,679,057,667 639,441,635 ( 38.08 %) 33,675,818 ( 2.006 %) 38.08 %

Shareholders

NameEquities%Valuation
ROCHE HOLDING AG
59.89 %
1,005,670,000 59.89 % 30 597 M ¥
CHUGAI PHARMACEUTICAL CO., LTD
2.010 %
33,743,700 2.010 % 1 027 M ¥
Sumitomo Life Insurance Co.
0.5360 %
9,000,000 0.5360 % 274 M ¥
TOKIO MARINE HOLDINGS, INC.
0.3383 %
5,680,887 0.3383 % 173 M ¥
MFS International (UK) Ltd.
0.1959 %
3,289,500 0.1959 % 100 M ¥
Amundi Asset Management SA (Investment Management)
0.1162 %
1,951,102 0.1162 % 59 M ¥
RBC Global Asset Management (Asia) Ltd.
0.0765 %
1,284,384 0.0765 % 39 M ¥
State Street Global Advisors Ltd.
0.0682 %
1,145,423 0.0682 % 35 M ¥
Chugai Pharmaceutical Restricted Stock Compensation Plan
0.0649 %
1,090,300 0.0649 % 33 M ¥
Sumitomo Mitsui Trust Asset Management Co., Ltd.
0.0543 %
911,800 0.0543 % 28 M ¥
NameEquities%Valuation
Todd Asset Management LLC
0.005591 %
187,755 0.005591 % 3 M ¥
Confluence Investment Management LLC
0.001179 %
39,586 0.001179 % 602 182 ¥
RhumbLine Advisers LP
0.000808 %
27,136 0.000808 % 412 793 ¥
PNC Investments LLC
0.000573 %
19,233 0.000573 % 292 572 ¥
Riverbridge Partners LLC
0.000393 %
13,200 0.000393 % 200 798 ¥
GAMMA Investing LLC
0.000189 %
6,337 0.000189 % 96 398 ¥
abrdn Investments Luxembourg SA
0.000020 %
667 0.000020 % 10 146 ¥
Operose Advisors LLC
0.000016 %
535 0.000016 % 8 138 ¥
Accent Capital Management LLC
0.000012 %
400 0.000012 % 6 085 ¥
Richardson Financial Services, Inc.
0.000000 %
14 0.000000 % 213 ¥

Holdings

NameEquities%Valuation
CHUGAI PHARMACEUTICAL CO., LTD
2.01%
 33,743,700 2.01% 1,026,622,715 $

Company contact information

Chugai Pharmaceutical Co., Ltd.

Nihonbashi Mitsui Tower, 15/F 2-1-1 Nihonbashi-Muromachi

103-8324, Tokyo

+81 3 3281 6611

http://www.chugai-pharm.co.jp
address Chugai Pharmaceutical Co., Ltd(4519)

Sector

Healthcare
Pharmaceuticals & Medical Research
Pharmaceuticals
Pharmaceuticals
Other Pharmaceuticals

Sales per Business

Sales per region

Ratings for Chugai Pharmaceutical Co., Ltd

Trading Rating
Investor Rating
ESG Refinitiv
A-
More Ratings

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
14
Last Close Price
5,786 JPY
Average target price
5,946 JPY
Spread / Average Target
+2.77%
Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Other Pharmaceuticals

1st Jan change Capi.
CHUGAI PHARMACEUTICAL CO., LTD Stock Chugai Pharmaceutical Co., Ltd
+12.00% 58.94B
ELI LILLY AND COMPANY Stock Eli Lilly and Company
+55.55% 816B
NOVO NORDISK A/S Stock Novo Nordisk A/S
+41.14% 634B
JOHNSON & JOHNSON Stock Johnson & Johnson
-6.83% 351B
MERCK & CO., INC. Stock Merck & Co., Inc.
+17.15% 323B
ABBVIE INC. Stock AbbVie Inc.
+7.09% 293B
ASTRAZENECA PLC Stock AstraZeneca PLC
+13.58% 238B
ROCHE HOLDING AG Stock Roche Holding AG
+1.68% 222B
NOVARTIS AG Stock Novartis AG
+13.73% 218B
AMGEN INC. Stock Amgen Inc.
+7.87% 167B
Other Pharmaceuticals
  1. Stock Market
  2. Equities
  3. 4519 Stock
  4. Company Chugai Pharmaceutical Co., Ltd